1022 related articles for article (PubMed ID: 32839612)
1. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function.
Winkler ES; Bailey AL; Kafai NM; Nair S; McCune BT; Yu J; Fox JM; Chen RE; Earnest JT; Keeler SP; Ritter JH; Kang LI; Dort S; Robichaud A; Head R; Holtzman MJ; Diamond MS
Nat Immunol; 2020 Nov; 21(11):1327-1335. PubMed ID: 32839612
[TBL] [Abstract][Full Text] [Related]
2. Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection.
Rathnasinghe R; Strohmeier S; Amanat F; Gillespie VL; Krammer F; García-Sastre A; Coughlan L; Schotsaert M; Uccellini MB
Emerg Microbes Infect; 2020 Dec; 9(1):2433-2445. PubMed ID: 33073694
[TBL] [Abstract][Full Text] [Related]
3. Role of neutrophil chemoattractant CXCL5 in SARS-CoV-2 infection-induced lung inflammatory innate immune response in an
Liang Y; Li H; Li J; Yang ZN; Li JL; Zheng HW; Chen YL; Shi HJ; Guo L; Liu LD
Zool Res; 2020 Nov; 41(6):621-631. PubMed ID: 33045777
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 infection in the lungs of human ACE2 transgenic mice causes severe inflammation, immune cell infiltration, and compromised respiratory function.
Winkler ES; Bailey AL; Kafai NM; Nair S; McCune BT; Yu J; Fox JM; Chen RE; Earnest JT; Keeler SP; Ritter JH; Kang LI; Dort S; Robichaud A; Head R; Holtzman MJ; Diamond MS
bioRxiv; 2020 Jul; ():. PubMed ID: 32676600
[TBL] [Abstract][Full Text] [Related]
5. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice.
Bao L; Deng W; Huang B; Gao H; Liu J; Ren L; Wei Q; Yu P; Xu Y; Qi F; Qu Y; Li F; Lv Q; Wang W; Xue J; Gong S; Liu M; Wang G; Wang S; Song Z; Zhao L; Liu P; Zhao L; Ye F; Wang H; Zhou W; Zhu N; Zhen W; Yu H; Zhang X; Guo L; Chen L; Wang C; Wang Y; Wang X; Xiao Y; Sun Q; Liu H; Zhu F; Ma C; Yan L; Yang M; Han J; Xu W; Tan W; Peng X; Jin Q; Wu G; Qin C
Nature; 2020 Jul; 583(7818):830-833. PubMed ID: 32380511
[TBL] [Abstract][Full Text] [Related]
6. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
7. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of K18-
Moreau GB; Burgess SL; Sturek JM; Donlan AN; Petri WA; Mann BJ
Am J Trop Med Hyg; 2020 Sep; 103(3):1215-1219. PubMed ID: 32723427
[TBL] [Abstract][Full Text] [Related]
9. Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease.
Golden JW; Cline CR; Zeng X; Garrison AR; Carey BD; Mucker EM; White LE; Shamblin JD; Brocato RL; Liu J; Babka AM; Rauch HB; Smith JM; Hollidge BS; Fitzpatrick C; Badger CV; Hooper JW
JCI Insight; 2020 Oct; 5(19):. PubMed ID: 32841215
[TBL] [Abstract][Full Text] [Related]
10. Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment.
Sun J; Zhuang Z; Zheng J; Li K; Wong RL; Liu D; Huang J; He J; Zhu A; Zhao J; Li X; Xi Y; Chen R; Alshukairi AN; Chen Z; Zhang Z; Chen C; Huang X; Li F; Lai X; Chen D; Wen L; Zhuo J; Zhang Y; Wang Y; Huang S; Dai J; Shi Y; Zheng K; Leidinger MR; Chen J; Li Y; Zhong N; Meyerholz DK; McCray PB; Perlman S; Zhao J
Cell; 2020 Aug; 182(3):734-743.e5. PubMed ID: 32643603
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
[TBL] [Abstract][Full Text] [Related]
12. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2.
Jiang RD; Liu MQ; Chen Y; Shan C; Zhou YW; Shen XR; Li Q; Zhang L; Zhu Y; Si HR; Wang Q; Min J; Wang X; Zhang W; Li B; Zhang HJ; Baric RS; Zhou P; Yang XL; Shi ZL
Cell; 2020 Jul; 182(1):50-58.e8. PubMed ID: 32516571
[TBL] [Abstract][Full Text] [Related]
14. Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice.
Case JB; Rothlauf PW; Chen RE; Kafai NM; Fox JM; Smith BK; Shrihari S; McCune BT; Harvey IB; Keeler SP; Bloyet LM; Zhao H; Ma M; Adams LJ; Winkler ES; Holtzman MJ; Fremont DH; Whelan SPJ; Diamond MS
Cell Host Microbe; 2020 Sep; 28(3):465-474.e4. PubMed ID: 32798445
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 preclinical models: human angiotensin-converting enzyme 2 transgenic mice.
Lutz C; Maher L; Lee C; Kang W
Hum Genomics; 2020 Jun; 14(1):20. PubMed ID: 32498696
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract.
Hou YJ; Okuda K; Edwards CE; Martinez DR; Asakura T; Dinnon KH; Kato T; Lee RE; Yount BL; Mascenik TM; Chen G; Olivier KN; Ghio A; Tse LV; Leist SR; Gralinski LE; Schäfer A; Dang H; Gilmore R; Nakano S; Sun L; Fulcher ML; Livraghi-Butrico A; Nicely NI; Cameron M; Cameron C; Kelvin DJ; de Silva A; Margolis DM; Markmann A; Bartelt L; Zumwalt R; Martinez FJ; Salvatore SP; Borczuk A; Tata PR; Sontake V; Kimple A; Jaspers I; O'Neal WK; Randell SH; Boucher RC; Baric RS
Cell; 2020 Jul; 182(2):429-446.e14. PubMed ID: 32526206
[TBL] [Abstract][Full Text] [Related]
17. A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies.
Hassan AO; Case JB; Winkler ES; Thackray LB; Kafai NM; Bailey AL; McCune BT; Fox JM; Chen RE; Alsoussi WB; Turner JS; Schmitz AJ; Lei T; Shrihari S; Keeler SP; Fremont DH; Greco S; McCray PB; Perlman S; Holtzman MJ; Ellebedy AH; Diamond MS
Cell; 2020 Aug; 182(3):744-753.e4. PubMed ID: 32553273
[TBL] [Abstract][Full Text] [Related]
18. Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling.
Israelow B; Song E; Mao T; Lu P; Meir A; Liu F; Alfajaro MM; Wei J; Dong H; Homer RJ; Ring A; Wilen CB; Iwasaki A
J Exp Med; 2020 Dec; 217(12):. PubMed ID: 32750141
[TBL] [Abstract][Full Text] [Related]
19. The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development.
Zhang Z; Zhou L; Liu Q; Zheng Y; Tan X; Huang Z; Guo M; Wang X; Chen X; Liang S; Li W; Song K; Yan K; Li J; Li Q; Zhang Y; Yang S; Cai Z; Dai M; Xian Q; Shi ZL; Xu K; Lan K; Chen Y
Emerg Microbes Infect; 2024 Dec; 13(1):2353302. PubMed ID: 38753462
[TBL] [Abstract][Full Text] [Related]
20. Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2.
Golden JW; Li R; Cline CR; Zeng X; Mucker EM; Fuentes-Lao AJ; Spik KW; Williams JA; Twenhafel N; Davis N; Moore JL; Stevens S; Blue E; Garrison AR; Larson DD; Stewart R; Kunzler M; Liu Y; Wang Z; Hooper JW
mBio; 2022 Feb; 13(1):e0290621. PubMed ID: 35073750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
